# Gender Related Differences in the Acute Effects of Delta-9-Tetrahydrocannabinol in Healthy Humans: Sub-Study I

> **NCT02811510** · PHASE1 · RECRUITING · sponsor: **Yale University** · enrollment: 40 (estimated)

## Conditions studied

- Cannabis

## Interventions

- **DRUG:** Placebo
- **DRUG:** Dronabinol

## Key facts

- **NCT ID:** NCT02811510
- **Lead sponsor:** Yale University
- **Sponsor class:** OTHER
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2016-06
- **Primary completion:** 2026-06
- **Final completion:** 2026-12
- **Target enrollment:** 40 (ESTIMATED)
- **Last updated:** 2025-06-10


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02811510

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02811510, "Gender Related Differences in the Acute Effects of Delta-9-Tetrahydrocannabinol in Healthy Humans: Sub-Study I". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT02811510. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*